Tamara Steffens is managing director of Thomson Reuters Ventures, where she invests in early-stage companies building around legal, tax, accounting, and enterprise workflow.
Corporate venture capital can look like a shortcut to customers, distribution, and credibility, but Steffens says founders need to understand what has to be true before strategic money can actually help.
In this conversation, we get into what happens after Thomson Reuters Ventures joins your cap table, how founders can turn a corporate investor into real product or go-to-market leverage, and why inflated TAM slides can work against you.
We also talk about what founders should do before and after the check clears, why some good businesses should avoid venture capital entirely, and why she says every founder should be thinking earlier about exit paths.
RUNTIME: 36:14
EPISODE BREAKDOWN
(1:53) An Overview of Thomson Reuters Ventures
(3:57) CVC Expectations: When Strategic Capital Can Actually Help
(7:09) Why Your TAM Needs to Match the Product You Actually Have
(10:04) When Strategic Capital Becomes Product Leverage
(13:13) What Founders Should Do Before and After the Check Clears
(22:18) How CVC Evaluates Founders When the Market Gets Frothy
(29:05) Building the Relationship Before Series A
(31:30) Why Exit Paths Matter Earlier Than You Think
LINKS
Tamara Steffens
Thomson Reuters Ventures
Thomson Reuters
Fund/Build/Scale Founder Narrative Advisory
SUBSCRIBE
📥 Get the Fund/Build/Scale newsletter on Beehiiv: https://fundbuildscale.beehiiv.com/
📺 Watch Fund/Build/Scale on YouTube: https://www.youtube.com/channel/UCFFH4cs2B1BKatPGs8SFRJw
📸 Follow Fund/Build/Scale on Instagram: https://www.instagram.com/fundbuildscale/
